1Alpha,25-dihydroxyvitamin D 3 induces de novo E-cadherin expression in triple-negative breast cancer cells by CDH1-promoter demethylation

Anticancer Research

Volumn 32, Issue 1 PART 2, 2012, Pages 249-257

  Lopes, Nair ^a   Carvalho, Joana ^a   Durães, Cecília ^a   Sousa, Bárbara ^a   Gomes, Madalena ^a   Costa, José Luis ^a   Oliveira, Carla ^a,b   Paredes, Joana ^a,b   Schmitt, Fernando ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b University of Porto   (Portugal)

Author keywords

1a,25(oh) 2d 3; Breast cancer; E cadherin; Methylation; VDR; Vitamin D

Indexed keywords

CALCITRIOL; UVOMORULIN; VITAMIN D RECEPTOR;

BREAST CANCER; CANCER CELL; CANCER CHEMOTHERAPY; CONFERENCE PAPER; CONTROLLED STUDY; DEMETHYLATION; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN METHYLATION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

BLOTTING, WESTERN; BREAST NEOPLASMS; CADHERINS; DNA METHYLATION; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOENZYME TECHNIQUES; PROMOTER REGIONS, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, ERBB-2; RECEPTORS, CALCITRIOL; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RNA, MESSENGER; RNA, SMALL INTERFERING; TUMOR CELLS, CULTURED; VITAMIN D;

EID: 84856024024     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (29)

1. Perou CM, Sortie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL, Brown PO and Botstein D: Molecular portraits of human breast tumours. Nature 406(6797): 747-752, 2000.
2. Sortie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Eystein Lonning P and Borresen-Dale AL: Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98(19): 10869-10874, 2001. (Pubitemid 32878711)
3. Korsching E, Jeffrey SS, Meinerz W, Decker T, Boecker W and Buerger H: Basal carcinoma of the breast revisited: an old entity with new interpretations. J Clin Pathol 61(5): 553-560, 2008. (Pubitemid 351678206)
4. Kuroda N, Fujishima N, Inoue K, Ohara M, Hirouchi T, Mizuno K, Hayashi Y and Lee GH: Basal-like carcinoma of the breast: further evidence of the possibility that most metaplastic carcinomas may be actually basal-like carcinomas. Med Mol Morphol 41(2): 117-120, 2008. (Pubitemid 351915428)
5. Reis-Filho JS, Milanezi F, Steele D, Savage K, Simpson PT, Nesland JM, Pereira EM, Lakhani SR and Schmitt FC: Metaplastic breast carcinomas are basal-like tumours. Histopathology 49(1): 10-21, 2006. (Pubitemid 43972916)
6. Gwin K, Buell-Gutbrod R, Tretiakova M and Montag A: Epithelial-to- mesenchymal transition in metaplastic breast carcinomas with chondroid differentiation: expression of the E-cadherin repressor Snail. Appl Immunohistochem Mol Morphol 18(6): 526-531, 2010.
7. Reis-Filho JS, Milanezi F, Paredes J, Silva P, Pereira EM, Maeda SA, de Carvalho LV and Schmitt FC: Novel and classic myoepithelial/stem cell markers in metaplastic carcinomas of the breast. Appl Immunohistochem Mol Morphol 11(1): 1-8, 2003. (Pubitemid 36372997)
8. Bae SY, Lee SK, Koo MY, Hur SM, Choi MY, Cho DH, Kim S, Choe JH, Lee JE, Kim JH, Kim JS, Nam SJ and Yang JH: The prognoses of metaplastic breast cancer patients compared to those of triple-negative breast cancer patients. Breast Cancer Res Treat 126(2): 471-478, 2011.
9. Okada N, Hasebe T, Iwasaki M, Tamura N, Akashi-Tanaka S, Hojo T, Shibata T, Sasajima Y, Kanai Y and Kinoshita T: Metaplastic carcinoma of the breast. Hum Pathol 41(7): 960-970, 2010.
10. Eisman JA, Martin TJ, MacIntyre I and Moseley JM: 1,25-Dihydroxyvitamin- D-receptor in breast cancer cells. Lancet 2(8156-8157): 1335-1336, 1979.
11. Lopes N, Sousa B, Martins D, Gomes M, Vieira D, Veronese LA, Milanezi F, Paredes J, Costa JL and Schmitt F: Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions. BMC Cancer 10: 483-492, 2010.
12. Deeb KK, Trump DL and Johnson CS: Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer 7(9): 684-700, 2007. (Pubitemid 47327412)
13. Pendas-Franco N, Gonzalez-Sancho JM, Suarez Y, Aguilera O, Steinmeyer A, Gamallo C, Berciano MT, Lafarga M and Munoz A: Vitamin D regulates the phenotype of human breast cancer cells. Differentiation 75(3): 193-207, 2007. (Pubitemid 46426618)
14. Palmer HG, Gonzalez-Sancho JM, Espada J, Berciano MT, Puig I, Baulida J, Quintanilla M, Cano A, de Herreros AG, Lafarga M and Munoz A: Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. J Cell Biol 154(2): 369-387, 2001. (Pubitemid 34286147)
15. 3 analogue involves the induction of p21waf1, p27kip1 and E-cadherin. J Mol Endocrinol 19(1): 15-27, 1997.
16. Charafe-Jauffret E, Ginestier C, Monville F, Finetti P, Adelaide J, Cervera N, Fekairi S, Xerri L, Jacquemier J, Birnbaum D and Bertucci F: Gene expression profiling of breast cell lines identifies potential new basal markers. Oncogene 25(15): 2273-2284, 2006.
17. Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, Fevr T, Clark L, Bayani N, Coppe JP, Tong F, Speed T, Spellman PT, DeVries S, Lapuk A, Wang NJ, Kuo WL, Stilwell JL, Pinkel D, Albertson DG, Waldman FM, McCormick F, Dickson RB, Johnson MD, Lippman M, Ethier S, Gazdar A and Gray JW: A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10(6): 515-527, 2006. (Pubitemid 44854747)
18. Oliveira C, Sousa S, Pinheiro H, Karam R, Bordeira-Carrico R, Senz J, Kaurah P, Carvalho J, Pereira, R, Gusmao L, Wen X, Cipriano MA, Yokota J, Carneiro F, Huntsman D and Seruca R: Quantification of epigenetic and genetic 2nd hits in CDH1 during hereditary diffuse gastric cancer syndrome progression. Gastroenterology 136(7): 2137-2148, 2009.
19. Becker KF, Atkinson MJ, Reich U, Becker I, Nekarda H, Siewert JR and Hofler H: E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res 54(14): 3845-3852, 1994. (Pubitemid 24241205)
20. Berx G, Cleton-Jansen AM, Nollet F, de Leeuw WJ, van de Vijver M, Cornelisse C and van Roy F: E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. EMBO J 14(24): 6107-6115, 1995. (Pubitemid 26007298)
21. Wendt MK, Taylor MA, Schiemann BJ and Schiemann WP: Downregulation of epithelial Cadherin is required to initiate metastatic outgrowth of breast cancer. Mol Biol Cell 22(14): 2423-2435, 2011.
22. Gagnon J, Shaker S, Primeau M, Hurtubise A and Momparler R L: Interaction of 5-aza-2′-deoxycytidine and depsipeptide on antineoplastic activity and activation of 14-3-3sigma, E-cadherin and tissue inhibitor of metalloproteinase 3 expression in human breast carcinoma cells. Anticancer Drugs 14(3): 193-202, 2003. (Pubitemid 36418938)
23. Pan L, Matloob AF, Du J, Pan H, Dong Z, Zhao J, Feng Y, Zhong Y, Huang B and Lu J: Vitamin D stimulates apoptosis in gastric cancer cells in synergy with trichostatin A /sodium butyrate-induced and 5-aza-2′-deoxycytidine- induced PTEN upregulation. FEBS J 277(4): 989-999, 2010.
24. Godman CA, Joshi R, Tierney BR, Greenspan E, Rasmussen TP, Wang HW, Shin DG, Rosenberg DW and Giardina C: HDAC3 impacts multiple oncogenic pathways in colon cancer cells with effects on Wnt and vitamin D signaling. Cancer Biol Ther 7(10): 1570-1580, 2008.
25. 3 stimulates the assembly of adherens junctions in keratinocytes: involvement of protein kinase C. Endocrinology 138(6): 2241-2248, 1997.
26. Niitsu N, Hayashi Y, Sugita K and Honma Y: Sensitization by 5-aza-2′-deoxycytidine of leukaemia cells with MLL abnormalities to induction of differentiation by all-trans retinoic acid and 1alpha,25- dihydroxyvitamin D3. Br J Haematol 112(2): 315-326, 2001. (Pubitemid 32183472)
27. 3-induced DNA methylation suppresses the human CYP27B1 gene. Mol Cell Endocrinol 265-266: 168-173, 2007.
28. Kouchi Z, Fujiwara Y, Yamaguchi H, Nakamura Y and Fukami K: Phosphatidylinositol 5-phosphate 4-kinase type II beta is required for vitamin D receptor-dependent E-cadherin expression in SW480 cells. Biochem Biophys Res Commun 408(4): 523-529, 2011.
29. Pereira F, Barbachano A, Silva J, Bonilla F, Campbell M J, Munoz A and Larriba MJ: KDM6B/JMJD3 histone demethylase is induced by vitamin D and modulates its effects in colon cancer cells. Hum Mol Genet, 2011 (to be published).